Temple Therapeutics, a women's health company, launched a spinoff venture for orthopedic sports medicine, according to a Sept. 9 news release.
Temple OrthoBiologics aims to address issues with scar tissue in joints, the news release said. The company's flagship product is TX-33, which is designed for muscle recovery and repair in athletes. The product aims to prevent scar tissue from forming after an injury or surgery.
The company's research and development hub is in Belgium and has partnerships in the U.S., Netherlands and Canada.